Divestment19 May 2026, 11:11 pm
HCG to Divest BACC Healthcare to Inviga for ₹37.64 Cr
AI Summary
HealthCare Global Enterprises Ltd (HCG) has approved the divestment of its entire equity shareholding in its wholly-owned subsidiary, BACC Health Care Private Limited, to Inviga Healthcare Fund I and its nominee. The consideration for the sale is ₹37,64,44,788, based on a Share Purchase Agreement (SPA). BACC, engaged in fertility and reproductive healthcare, is not a core business activity for HCG. The transaction, a related party transaction, has been approved by the Audit Committee and the Board, finalized after a competitive process, and is on an arm’s length basis. The divestment aligns with HCG's strategic objectives, allowing reinvestment in high-growth areas and cancer services.
Key Highlights
- HCG to sell its entire stake in BACC Health Care to Inviga Healthcare Fund I.
- The sale consideration is ₹37.64 crore.
- BACC's revenue was ₹60.45 Cr, contributing 4.45% to HCG's standalone revenue in FY26.
- BACC's net worth was ₹17.53 Cr, representing 1.09% of HCG's net worth as of March 31, 2026.
- The divestment will allow HCG to focus on core business and reinvest in high-growth areas.